Evaluation of Aphrodisiac Activity of AHPL/AYCAP/0114 Capsule in Sexually Sluggish Male Rats

ABSTRACT

Background: Male sexual dysfunction includes a wide range of problems such as erectile dysfunction and premature ejaculation, for which medical help is sought. The conventional use of various pharmacological and nonpharmacological measures are associated with multiple adverse events. Hence, a polyherbal formulation AHPL/AYCAP/0114 capsule was developed to provide safe and effective therapeutic option. Objectives: The aim of this study was to evaluate the aphrodisiac potential of AHPL/AYCAP/0114 capsule by assessing sexual behavior parameters such as mount frequency (MF), mount latency (ML), intromission frequency (IF), intromission latency (IL), ejaculation latency (EL), and ejaculation frequency (EF) in sexually sluggish male rats. Materials and Methods: Male Wistar rats were divided into six groups (n = 6) and treated with testosterone (30 mg/kg), sildenafil citrate (0.5 mg/kg), and AHPL/AYCAP/0114 capsule (110, 220, and 440 mg/kg) as Group II, Group III, and Group IV, V, and VI, respectively, for 28 days. Group I animals served as control. Then, they were introduced to sexually active female rats and their sexual behavior was recorded. Results: A significant increase in MF, IF, and EF was observed in all the AHPL/AYCAP/0114 capsule groups as compared to control group. A significant decrease in ML, IL, and EL was observed in all the AHPL/AYCAP/0114 capsule groups as compared to control group. AHPL/AYCAP/0114 capsule was well tolerated by rats. Discussion: Increase in MF, IF, and EF and reduction in ML, IL, and EL are indicative of increased sexual motivation and arousal and prolonged duration of coitus. This suggests enhanced sexual performance in sexually sluggish animals treated with AHPL/AYCAP/0114 capsule. Conclusion: It can be concluded that AHPL/AYCAP/0114 capsule possesses aphrodisiac activity and can be used in erectile dysfunction and loss of libido.

KEYWORDS

• AHPL/AYCAP/0114 capsule
• aphrodisiac
• erectile dysfunction
• loss of libido
• premature ejaculation

Showing references and in-text citations exactly as published.

• DOI10.4103/pm.pm_363_17Copy

RELATED ARTICLES

Matched on section and article type within this issue of Pharmacogn. Mag..

• Article · VOLUME 14, ISSUE 55SEvaluation and Understanding the Molecular Basis of the Antimethicillin‑Resistant Staphylococcus aureus Activity of Secondary Metabolites Isolated from Lamium amplexicauleMohammed M. Ghoneim, Arafa Musa, Atef A. El‑Hela, Khaled M. Elokely · pp. S3–S7Original ArticleSame type: Article
• Article · VOLUME 14, ISSUE 55SQuinic Acid Attenuates Oral Cancer Cell Proliferation by Downregulating Cyclin D1 Expression and Akt SignalingAnjana Singh, Shyam Singh Chauhan, Vishwas Tripathi · pp. S14–S19Original ArticleSame type: Article
• Article · VOLUME 14, ISSUE 55SAntioxidant, Anti‑inflammatory, and Antiproliferative Activity of Extracts Obtained from Tabebuia Rosea (Bertol.) DCFrancisco Javier Jiménez‑González, Jenny Marcela Vélez‑Gómez, Jhon Jairo Melchor‑Moncada, Luz Angela Veloza, Juan Carlos Sepúlveda‑Arias · pp. S25–S31Original ArticleSame type: Article
• Article · VOLUME 14, ISSUE 55SInsulinotropic and Cytoprotective Effect of L-theanine: An In vitro Dose Dependent StudyArpita Saha, Sirshendu Chatterjee, Ananya Chatterjee, Surmi Roy, Nirmalya Roy, Satinath Mukhopadhyay · pp. S36–S39Original ArticleSame type: Article